Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXTEND-IA TNK: Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase Part 2

NCT03340493 is registered in ClinicalTrials.gov with Neuroscience Trials Australia as lead sponsor.

NCT NCT03340493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03340493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXTEND-IA TNK: Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase Part 2
Lead sponsor
Neuroscience Trials Australia
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2017
Completion date
February 1, 2020
Enrollment
300 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke